NKGN
NKGen Biotech Inc

1,293
Loading...
Loading...
NKGen Biotech, Inc. is a clinical-stage biotechnology company, which focuses on the development and commercialization of innovative autologous, allogeneic, and CAR-NK cell therapies utilizing a proprietary SNK platform. Its product candidates are based on a proprietary manufacturing and cryopreservation process which produces SNK cells that have high potency as defined by parameters such as cytotoxicity, cytokine production, and activating receptor expression. The company was founded by Sangwoo Park in 2017 and is headquartered in Santa Ana, CA.
Sector:
Finance
Industry:
Financial Conglomerates
Employees:
N/A

Frequently Asked Questions

What is Market Cap of NKGen Biotech Inc?
What is the 52-week high for NKGen Biotech Inc?
What is the 52-week low for NKGen Biotech Inc?
What is NKGen Biotech Inc stock price today?
What was NKGen Biotech Inc stock price yesterday?
What is the PE ratio of NKGen Biotech Inc?
What is the Price-to-Book ratio of NKGen Biotech Inc?
What is the 50-day moving average of NKGen Biotech Inc?

Latest NKGN News

View

Advertisement. Remove ads.

Advertisement. Remove ads.